Cargando…

Clinical Assessment of the DiaSorin LIAISON SARS-CoV-2 Ag Chemiluminescence Immunoassay

BACKGROUND: Due to the large volume of tests needed in a relatively short time for screening and diagnosing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, antigen immunoassays may provide a potential supplement to molecular testing. This study was aimed to assess the clinica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salvagno, Gian Luca, Gianfilippi, Gianluca, Fiorio, Giacomo, Pighi, Laura, De Nitto, Simone, Henry, Brandon M., Lippi, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Communications and Publications Division (CPD) of the IFCC 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343054/ https://www.ncbi.nlm.nih.gov/pubmed/34421491

Ejemplares similares

Systematic Review of Diagnostic Accuracy of DiaSorin Liaison SARS-CoV-2 Antigen Immunoassay
por: Lippi, Giuseppe, et al.
Publicado: (2022)

Analytical and clinical evaluation of DiaSorin Liaison® Calprotectin fecal assay adapted for serum samples
por: Macias‐Muñoz, Laura, et al.
Publicado: (2022)

Analytical Performance of Quantitative DiaSorin Liaison SARS-COV-2 Antigen Test for the Asymptomatic Population
por: Fernández-Rivas, Gema, et al.
Publicado: (2022)

Analytical and clinical performance of the fully-automated LIAISONXL calprotectin immunoassay from DiaSorin in IBD patients
por: Vicente-Steijn, R., et al.
Publicado: (2020)

Clinical Utilization of DiaSorin Molecular Polymerase Chain Reaction in Pneumocystis Pneumonia
por: Damhorst, Gregory L, et al.
Publicado: (2022)

New Faecal Calprotectin Assay by IDS: Validation and Comparison to DiaSorin Method
por: Castiglione, Vincent, et al.
Publicado: (2022)

A Tale of Two Countries: DiaSorin Molecular’s Rapid Response to the COVID-19 Pandemic
por: Tabb, Michelle M., et al.
Publicado: (2022)

Comparative longitudinal variation of total IgG and IgA anti-SARS-CoV-2 antibodies in recipients of BNT162b2 vaccination
por: Lippi, Giuseppe, et al.
Publicado: (2021)

Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit
por: Salvagno, Gian Luca, et al.
Publicado: (2021)

Evaluación de la prueba Fluorecare de anticuerpos contra la proteína Spike del SARS-CoV-2 en la práctica real
por: Salvagno, Gian Luca, et al.
Publicado: (2021)

Variación longitudinal comparativa de los anticuerpos totales, IgG e IgA contra el SARS-CoV-2 en receptores de la vacuna BNT162b2
por: Lippi, Giuseppe, et al.
Publicado: (2022)

Population-based study of diagnostic assays for Borrelia infection: comparison of purified flagella antigen assay (Ideia™, Dako Cytomation) and recombinant antigen assay (Liaison(®), DiaSorin)
por: Petersen, Eskild, et al.
Publicado: (2008)

Molecular Detection of Candida auris Using DiaSorin Molecular Simplexa(®) Detection Kit: A Diagnostic Performance Evaluation
por: Ramírez, Juan David, et al.
Publicado: (2023)

Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers
por: Salvagno, Gian Luca, et al.
Publicado: (2021)

Clinical performance of the Roche Elecsys SARS-CoV-2 antigen fully automated electrochemiluminescence immunoassay
por: Salvagno, Gian Luca, et al.
Publicado: (2022)

Evaluation of the performance of DiaSorin molecular Pneumocystis jirovecii-CMV multiplex real-time PCR assay from bronchoalveolar lavage samples
por: Kilic, A., et al.
Publicado: (2020)

Detection of SARS-CoV-2 infection in asymptomatic populations using the DiaSorin molecular Simplexa and Roche Cobas EUA assays
por: Antonara, Stella, et al.
Publicado: (2022)

Evaluation of the DiaSorin LIAISON SARS-CoV-2 antigen assay on nasopharyngeal swabs in two different SARS-CoV-2 pandemic waves in Switzerland: The impact of the Omicron variant on its performance
por: Uster, Stephanie, et al.
Publicado: (2022)

Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers
por: Salvagno, Gian Luca, et al.
Publicado: (2021)

Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination
por: Salvagno, Gian Luca, et al.
Publicado: (2021)

418. Comparison of the Abbott SARS-CoV-2 IgG and DiaSorin LIASON SARS-CoV-2 S1/S2 IgG Antibody Assays
por: Schaack, Grace A, et al.
Publicado: (2020)

Validation of a modified CDC assay and performance comparison with the NeuMoDx™ and DiaSorin® automated assays for rapid detection of SARS-CoV-2 in respiratory specimens
por: Lima, Amorce, et al.
Publicado: (2020)

Analytical Evaluation of the New Beckman Coulter Access Procalcitonin (PCT) Chemiluminescent Immunoassay
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Total anti-SARS-CoV-2 antibodies measured 6 months after Pfizer-BioNTech COVID-19 vaccination in healthcare workers
por: Salvagno, Gian Luca, et al.
Publicado: (2022)

Serum C reactive protein predicts humoral response after BNT162b2 booster administration
por: Salvagno, Gian Luca, et al.
Publicado: (2022)

Association between viral load and positivization time of a SARS-CoV-2 rapid antigen test in routine nasopharyngeal specimens
por: Salvagno, Gian Luca, et al.
Publicado: (2022)

Variation of Total Anti-SARS-CoV-2 Antibodies After Primary BNT162b2 Vaccination and Homologous Booster
por: Salvagno, Gian Luca, et al.
Publicado: (2022)

Correlation Between Time to Positive Result of SARS-CoV-2 Rapid Antigen Self-Test and Viral Antigen Concentration
por: Salvagno, Gian Luca, et al.
Publicado: (2022)

Cellular immunity against SARS-CoV-2 depends on the serological status
por: Pighi, Laura, et al.
Publicado: (2023)

Impacto de la vacunación primaria con BNT162b2 y una dosis de refuerzo homóloga en los anticuerpos IgA contra SARS-CoV-2 en profesionales sanitarios seronegativos
por: Salvagno, Gian Luca, et al.
Publicado: (2022)

Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workers
por: Salvagno, Gian Luca, et al.
Publicado: (2022)

Comparison of five commercial anti-SARS-CoV-2 total antibodies and IgG immunoassays after vaccination with BNT162b2 mRNA
por: Danese, Elisa, et al.
Publicado: (2021)

SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load
por: Salvagno, Gian Luca, et al.
Publicado: (2022)

Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19
por: Rhoads, Daniel D., et al.
Publicado: (2020)

Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL
por: Van der Moeren, N., et al.
Publicado: (2021)

Efficacy of the Measurement of 25-Hydroxyvitamin D(2) and D(3) Levels by Using PerkinElmer Liquid Chromatography-Tandem Mass Spectrometry Vitamin D Kit Compared With DiaSorin Radioimmunoassay Kit and Elecsys Vitamin D Total Assay
por: Kwak, Ho-Seok, et al.
Publicado: (2015)

The strength of association between pre-and post-booster BNT162b2 anti-SARS-CoV-2 antibodies levels depends on the immunoassay
por: Salvagno, Gian Luca, et al.
Publicado: (2021)

Analytical evaluation of the novel Lumipulse G BRAHMS procalcitonin immunoassay
por: Ruzzenente, Orazio, et al.
Publicado: (2016)

Non-commutability of results of highly sensitive troponin I and T immunoassays
por: Lippi, Giuseppe, et al.
Publicado: (2012)

Corrigendum to ‘Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL’ [Journal of Clinical Virology 141 (2021) 104909]
por: Van der Moeren, N, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uhvmcbb457tv7hh4ksvrvj1i3v